The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Expression and Proteolysis of Vascular Endothelial Growth Factor is Increased in Chronic Wounds
Open accessAbstract
Degradation of angiogenic mediators might be an underlying cause of chronic wounds. To test this hypothesis, we evaluated the expression and integrity of vascular endothelial growth factor, a potent angiogenic mediator, and its receptors, Flt-1 and KDR, in chronic venous leg ulcerations. Immunohisto- chemical, in situ hybridization, and semiquantitative reverse transcriptase polymerase chain reaction analyses all indicate that expression of vascular endothelial growth factor is elevated in ulcerative tissue, with vascular endothelial growth factor mRNA being especially pronounced in the hyperplastic epithelium of the wound margin. Flt-1 and KDR protein and mRNA were detected in the papillary vessels in close vicinity to the lesional epithelium of chronic wounds. Although increased expression of vascular endothelial growth factor protein was detected in the epidermis, the intensity of this staining was weak compared with the epidermal staining in psoriatic lesions and compared with the strong vascular endothelial growth factor mRNA signal in chronic wounds and psoriasis. To analyze whether this apparent decrease in immunoreactivity could be the result of degradation of vascular endothelial growth factor by proteolytic activities from the wound environment, we examined the stability of recombinant vascular endothelial growth factor in wound fluid from chronic leg ulcers. As demonstrated by sodium dodecyl sulfate polyacrylamide gel electrophoresis, incubation of rVEGF165 with chronic, but not acute, wound fluid resulted in rapid proteolytic degradation of rVEGF165. Protease inhibitor studies indicate that serine proteases, such as plasmin, are involved in this degradation. Together, our data show that, although vascular endothelial growth factor expression is elevated in chronic wounds, increased proteolytic activity in this environment results in its degradation, which may contribute to an impaired wound healing response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a consequence, factors crucial for wound healing, e.g., the major proteinase inhibitors (e.g., α1-proteinase inhibitor and α2-macroglobulin), components of the provisional wound matrix (e.g., fibronectin and vitronectin), growth factors (e.g., PDGF, VEGF) are degraded or inactivated by proteolytic cleavage in chronic wounds [246, 247].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [247]
Experimental — accuracy not yet measuredIn the citing paper
“Last, in chronic wounds, there is a marked increase in serine proteases that degrades matrix components, including fibronectin, as well as various key growth factors, all of which are required for remodeling of the ECM and cell growth (38-41).”
From Wound repair and regeneration: Mechanisms, signaling, and translation (2014) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Matsudaira, P. T. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61070-1 · Cited by 4,951
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,100
Söker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,493
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,988
Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., & Leung, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1806 · Cited by 1,364
Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., & Ferrara, N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35712-0 · Cited by 1,127
Tumor Induction of VEGF Promoter Activity in Stromal Cells
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E.-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81731-6 · Cited by 996
Brown, L. F., Yeo, K. T., Berse, B., Yeo, T. K., Senger, D. R., Dvorak, H. F., & van de Water, L. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1375 · Cited by 878
Nissen, N., Polverini, P. J., Koch, A. E., Volin, M. V., Gamelli, R. L., & DiPietro, L. A. (1998) · Europe PMC (PubMed Central) · Cited by 833
Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes.
Frank, S., Hübner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G., & Werner, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12607 · Cited by 764
Detmar, M. J., Brown, L. F., Claffey, K. P., Yeo, K. T., Kocher, O. N., Jackman, R. W., Berse, B., & Dvorak, H. F. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.3.1141 · Cited by 684
Keyt, B. A., Berleau, L. T., Nguyen, H. V., Chen, H., Heinsohn, H. G., VANDLEN, R. L., & Ferrara, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7788 · Cited by 603
Detmar, M. J., Brown, L. F., Schön, M. P., Elicker, B. M., Velasco, P., Richard, L., Fukumura, D., Monsky, W. L., Claffey, K. P., & Jain, R. K. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00262.x · Cited by 550
Yager, D. R., Zhang, L.-Y., Liang, H.-X., Diegelmann, R. F., & Cohen, I. K. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12365637 · Cited by 389
Vaalamo, M., Mattila, L., Johansson, N., Kariniemi, A., Karjalainen‐Lindsberg, M., Kähäri, V., & Saarialho‐Kere, U. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12276722 · Cited by 287
Bullen, E. C., Longaker, M. T., Updike, D. L., Benton, R. L., Ladin, D. A., Hou, Z., & Howard, E. W. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12612786 · Cited by 271
Detmar, M. J., Brown, L. F., Berse, B., Jackman, R. W., Elicker, B. M., Dvorak, H. F., & Claffey, K. P. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12286453 · Cited by 263
Herrick, S. E., Sloan, P., McGurk, M., Freak, L., McCollum, C. N., & Ferguson, M. W. J. (1992) · PubMed Central · Cited by 246
Grinnell, F., Ho, C.-H., & Wysocki, A. B. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12499839 · Cited by 243
Detmar, M. J., Yeo, K.-T., Nagy, J. A., Water, L. V. D., Brown, L. F., Berse, B., Elicker, B. M., Ledbetter, S., & Dvorak, H. F. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12312542 · Cited by 242
Plouët, J., Moro, F., Bertagnolli, S., Coldeboeuf, N., Mazarguil, H., Clamens, S., & Bayard, F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13390 · Cited by 239
Matrix Metalloproteinases, Gelatinase and Collagenase, in Chronic Leg Ulcers
Weckroth, M., Vaheri, A. I., Lauharanta, J., Sorsa, T., & Konttinen, Y. T. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12340167 · Cited by 237
Grinnell, F., & Zhu, M. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12342990 · Cited by 232
Söker, S., Gollamudi-Payne, S., Fidder, H. H., Charmahelli, H., & Klagsbrun, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31582 · Cited by 201
Uk, F., Bollinger, A., Huch, R., & Huch, A. (1984) · Circulation · doi:10.1161/01.cir.70.5.806 · Cited by 178
Chronic Wounds: Pathophysiologic and Experimental Considerations
Falanga, V. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12472373 · Cited by 173
Brown, L. F., Olbricht, S. M., Berse, B., Jackman, R. W., Matsueda, G. R., Tognazzi, K., Manseau, E. J., Dvorak, H. F., & Water, L. V. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2801 · Cited by 150
Brown, L. F., Harrist, T. J., Yeo, K.-T., Ståhle‐Bäckdahl, M., Jackman, R. W., Berse, B., Tognazzi, K., Dvorak, H. F., & Detmar, M. J. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12606974 · Cited by 148
Flamme, I., Krieg, M., & Plate, K. H. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65541-1 · Cited by 119
Self-citationBinding and activation of plasminogen at the surface of Staphylococcus aureus
Kuusela, P., & Saksela, O. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19397.x · Cited by 111
Proteolytic activity in leg ulcer exudate
Palolahti, M., Lauharanta, J., Stephens, R. W., Kuusela, P., & Vaheri, A. (1993) · Experimental Dermatology · doi:10.1111/j.1600-0625.1993.tb00196.x · Cited by 108
Rao, C. N., Ladin, D. A., Chilukuri, K., Woodley, D. T., Liu, Y. Y., & Hou, Z. Z. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12323503 · Cited by 108
Gille, J., Khalik, M., König, V., & Kaufmann, R. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00418.x · Cited by 89
Microvascular changes in chronic venous insufficiency—a review
Leu, A. (1995) · Cardiovascular Surgery · doi:10.1016/0967-2109(95)93871-l · Cited by 89
Kuusela, P., Ullberg, M., Saksela, O., & Kronvall, G. (1992) · Infection and Immunity · doi:10.1128/iai.60.1.196-201.1992 · Cited by 83
Protease inhibitors protect growth factor activity in chronic wounds
Wlaschek, M., Peus, D., Achterberg, V., Meyer-Ingold, W., & Scharffetter-Kochanek, K. (1997) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1997.tb03804.x · Cited by 81
Morphology of chronic venous insufficiency--light and electron microscopic examinations.
Hj, L. (1991) · PubMed · Cited by 59
Hoffman, R. M., Starkey, S., & Coad, J. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00429.x · Cited by 39
Capillary underperfusion in chronic venous insufficiency: a cause for leg ulceration?
LUETOLF, O., Bull, R. H., Bates, D. O., & Mortimer, P. S. (1993) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1993.tb00166.x · Cited by 29
Schaefer, B. M., Stark, H.-J., Fusenig, N. E., Todd, R. F., & Kramer, M. D. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1333 · Cited by 22
Structure-Actmty Relationships of Inhibitors Derived from 3-Amidinophenylalanine
Stürzebecher, J., Prasa, D., Wikström, P., & Vieweg, H. (1995) · Journal of enzyme inhibition · doi:10.3109/14756369509040683 · Cited by 20
Self-citationScelsi, R., Scelsi, L., Cortinovis, R., & Poggi, P. (1994) · PubMed · Cited by 18
Research works printed but not linked: 4
- Dvorak, 1995, VPF/VEGF, microvascular hypermeability, and angiogenesis, Am J Path, 146, 1029
- Lei, 1998, Identification and characterization of a new splicing variant of VEGF.VEGF183, Biochem Biophys Acta, 1443, 400
- Nissen, 1998, VEGF mediates angiogenic activity during the proliferative phase of wound healing, Am J Path, 152, 1445
- Stürzebecher, 1996, 3-Amidinophenylalanine-derivates as inhibitors of enzymes of the fibrinolytic system, Ann Hematol, 72, A33
Cited by
Sorted by citations
Regulation of Wound Healing by Growth Factors and Cytokines
WERNER, S., & GROSE, R. (2003) · Physiological Reviews · doi:10.1152/physrev.2003.83.3.835 · Cited by 3,629
Wound repair and regeneration: Mechanisms, signaling, and translation
Eming, S. A., Martin, P., & Tomic-Canic, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009337 · Cited by 3,562
Self-citationInflammation in Wound Repair: Molecular and Cellular Mechanisms
Eming, S. A., Krieg, T., & Davidson, J. M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700701 · Cited by 2,429
Self-citationTransition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Wound healing: cellular mechanisms and pathological outcomes
Wilkinson, H. N., & Hardman, M. J. (2020) · Open Biology · doi:10.1098/rsob.200223 · Cited by 1,975
Metadata
- Authors
- Lauer, G., Sollberg, S., Cole, M., Krieg, T., Eming, S. A., Flamme, I., Stürzebecher, J., & Mann, K.
- Affiliations
- University of Cologne (DE)
- Friedrich Schiller University Jena (DE)
- Max Planck Institute of Biochemistry (DE)
- Corresponding author
- Eming, Sabine A.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2000-07
- Volume
- 115
- Issue
- 1
- Pages
- 12-18
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2004127276
- Cited by
- 349
- References
- 43
- Citations by year
- 2026: 3 · 2025: 18 · 2024: 16 · 2023: 11 · 2022: 21 · 2021: 10 · 2020: 17 · 2019: 10 · 2018: 15 · 2017: 13 · 2016: 15 · 2015: 13 · 2014: 13 · 2013: 16 · 2012: 15
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Investigative Dermatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- vascular endothelial growth factor, chronic wounds, chronic venous leg ulcers, proteolysis, VEGF receptors, Flt-1, KDR, serine protease, plasmin, wound fluid, delayed wound healing, psoriasis, angiogenic mediators
- MeSH terms
- Chronic Disease, Drug Stability, Exudates and Transudates, Fibrinolysin, Humans, Leg Ulcer, Lymphokines, Protease Inhibitors, Proto-Oncogene Proteins, Recombinant Proteins, RNA, Messenger, Wounds and Injuries, Up-Regulation, Gene Expression, Endothelial Growth Factors, Receptors, Growth Factor, Protein Isoforms, Receptor Protein-Tyrosine Kinases, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-1, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
